8.45 USD
▼+0.23-5.90%
盘后 9.05 +0.76%
2026-08-03
市值
$671.18M
市盈率
—
EPS
-1.27
股息率
—
52 周区间
8.03 – 18.31
成交量
2.19M
Beta
0.51
目标价
21.90
52W 低 8.0352W 高 18.31
价格走势
公司简介
Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-eros...